Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Laura Vangeel(Rega Institute for Medical Research), Dirk Jochmans(Rega Institute for Medical Research)
Cited by 430
Related Papers
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
|Journal of the American Chemical Society|2022|244
The Zinc-Finger Domain Containing Protein ZC4H2 Interacts with TRPV4, Enhancing Channel Activity and Turnover at the Plasma Membrane
|International Journal of Molecular Sciences|2020|17